• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Carbiotix

Less than 1K followers
Overview
Investor consensus
All
Press releases
ShowingAll content types

Forum discussions
I spotted this tiny but interesting Swedish company with a market value of €10 million a couple of days ago. The company was listed on Spotlight Stockholm in October 2019 Carbiotix | Pioneering onsite upcycling Carbiotix | Pioneering onsite upcycling Carbiotix is an award-winning...
12/18/2020, 12:48 PM
by Turskanpyytäjä
3
Things seem to be progressing well. Analyst Group’s analysis and the target price for the Base scenario have been raised to 22.2 SEK. Analyst Group Carbiotix Q1-21 - Analyst Group Ett analyshus med fokus på små- och microcap-bolag i Norden
1/20/2021, 3:45 PM
by Turskanpyytäjä
0
Three new contracts signed during Q4. https://carbiotix.com/news-item/66224
12/22/2020, 8:15 AM
by Turskanpyytäjä
0
There was some mention of it in that video. I couldn’t find any researched facts to support the claim, and of course, my understanding of foreign languages might also be playing tricks on me.
12/18/2020, 9:03 PM
by Turskanpyytäjä
0
Prebiotics certainly have a big market, and I take them myself and can attest to their benefits, even though I don’t have any serious gut issues. However, the claim of x10 effectiveness is quite interesting. Is there any proper data available for that?
12/18/2020, 8:49 PM
by Vodel1
0
Here’s a good introductory video about the company in the other official language. (If you understand English better, you can turn on subtitles on YouTube) The goal is to gain a foothold in the US market in 2021. For the prebiotic and medical food markets, the total market size is...
12/18/2020, 8:05 PM
by Turskanpyytäjä
0
Read more on our forum
Press release15.12.2025 klo 16.00

Carbiotix provides clarity on two previously communicated JCDA projects and how they will open new market opportunities

Carbiotix
Regulatory press release08.12.2025 klo 14.00

Carbiotix accelerates JCDA timeline with leading date producer and provides a NutraCycle project update with one week of trading remaining

Carbiotix
Regulatory press release26.11.2025 klo 14.45

Carbiotix signs NutraCycle agreement with global beverage solutions provider

Carbiotix

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release18.11.2025 klo 10.36

BioStock: Carbiotix' Chairman of the Board: "I'm very optimistic"

Carbiotix
Regulatory press release11.11.2025 klo 12.45

Carbiotix signs NutraCycle agreement with top 10 global date producer

Carbiotix
Regulatory press release04.11.2025 klo 12.30

Carbiotix signs NutraCycle agreement with top 10 global wine producer

Carbiotix
Press release07.10.2025 klo 10.19

BioStock: Carbiotix: ”We are trailblazers”

Carbiotix
Regulatory press release30.09.2025 klo 21.30

Carbiotix continues to add new NutraCycle projects in the third quarter

Carbiotix
Press release19.08.2025 klo 17.00

Carbiotix launches NutraCycle Formulation Lab service

Carbiotix
Regulatory press release30.06.2025 klo 14.00

Carbiotix ramps up JDA project negotiations - update of NutraCycle projects

Carbiotix